Dhruva Biswas, MD, PhD

Dr. Biswas is a Clinician-Data Scientist at the Cardiovascular Data Science (CarDS) Lab, an Associate Research Scientist at the Yale School of Medicine, and a Visiting Professor at King's College London, UK. His research aims to integrate AI-driven insights into clinical practice. This includes developing digital and molecular biomarkers to identify high-risk patients who are currently overlooked, evaluating the clinical contexts in which algorithm performance may be improved, and depicting the underlying pathophysiological mechanisms.

Dr. Biswas has authored more than 30 peer-reviewed publications, including as first author in Nature Medicine '19, Nature Cancer '22, and European Heart Journal Digital Health '25, and as corresponding author in Nature Cancer '25. His work has been featured in media outlets including The Times, the Independent, and Yahoo News. He has been recognized as ‘at the forefront of medical research’ by Nature Medicine.

Dr. Biswas started his medical training at the University of Cambridge, taking a MA in Neuroscience. Next, he joined the MB/PhD programme at University College London, undertaking PhD research between UCL Cancer Institute and the Francis Crick Institute, and graduating with PhD and MBBS degrees. His thesis work was recognized with international prizes, and he was also recognized as a Francis Crick Institute Translation Fellow for acting as a role model in the translational medicine community. Dr. Biswas then secured an Academic Foundation training position in the Cardiology stream at King’s College London. During his two-year medical internship, he also worked as a Postdoctoral Fellow at University College London.

In addition to his research and clinical duties, Dr. Biswas is passionate about mentorship and community engagement. He has supervised several MSc students, all of whom achieved distinction grades, and with three nominated for the Dean's Research Prize for the top project mark in their respective cohorts. He is also committed to patient and public involvement, including being involved with the South London structural heart team looking at equity of access to life-prolonging procedures.